A two-decade study finds notable differences in disease course and outcomes between ileal and colonic paediatric-onset ...

Physicians treating patients with Crohn's disease face a plethora of drug choices. Yet, overall rates of clinical response seem stable over time,1 suggesting the existence of a therapeutic ceiling ...

Crohn’s disease and celiac disease are both gastrointestinal (GI) conditions that can cause abdominal pain, diarrhea, and other symptoms. While both diseases cause inflammation in the GI tract ...

In a European study, higher consumption of fruits, vegetables, legumes, and potatoes was associated with a reduced risk of ...

Cedars-Sinai investigators have developed an investigational therapy that brought a significant number of patients with moderate to severe Crohn's disease into remission, according to a new study ...

JACK MAYE didn’t want to tell anybody. In his freshman year, when he took off his Bedford High School football helmet and flakes fell out, Maye’s teammates would tell him that he had some bad dandruff ...

JACK MAYE didn’t want to tell anybody. In his freshman year, when he took off his Bedford High School football helmet and flakes fell out, Maye’s teammates would tell him that he had some bad dandruff ...

Pediatric infliximab biosimilar use has risen significantly, reflecting evolving treatment patterns in inflammatory bowel ...

Johnson & Johnson targets pediatric Crohn disease (CD) treatment: The company has submitted a supplemental Biologics License Application to the FDA to expand Stelara (ustekinumab) use in children aged ...

Crohn’s disease, a chronic inflammatory condition of the digestive tract, poses unique challenges when it affects children. Young patients often experience symptoms such as abdominal pain ...